AI assistant
INSMED Inc — Director's Dealing 2021
Mar 12, 2021
30150_dirs_2021-03-12_de02b38f-752c-4500-9b50-6782e801b290.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2021-03-11
Reporting Person: SORIANO JOHN (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-11 | Common Stock | M | 23717 | $30.86 | Acquired | 53490 | Direct |
| 2021-03-11 | Common Stock | S | 23717 | $40 | Disposed | 29773 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-11 | Stock Option (right to buy) | $30.86 | M | 23717 | Disposed | 2028-01-22 | Common Stock (23717) | Direct |
Footnotes
F1: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F2: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.